News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis

Data shared at ASCO’s Gastrointestinal Cancers Symposium also included research that found hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers chemotherapy directly to cancer cells in the abdomen, increases survival for gastric cancer patients with peritoneal metastasis.

Read Source